The FMI Scientific Advisory Board (SAB) members assist the FMI co-directors and group leaders; they review research programs, and advise on policy and scientific matters. All of the SAB members are prominent experts in the field of biomedical research.
They are appointed for a three-year term.

Current SAB members

Prof. Naama Barkai

Weizmann Institute of Science, Rehovot, Israel

Prof. Catherine Dulac

Harvard University, Cambridge, USA

Prof. Gordon Fishell

Harvard Medical School, Cambridge, USA

Prof. Douglas Higgs

The Weatherall Institute of Molecular Medicine, Oxford, UK

Dr. Michaela Kneissel

Novartis Institutes for BioMedical Research, Basel, Switzerland

Prof. Edvard Moser

Kavli Institute for Systems Neuroscience, Trondheim, Norway

Prof. Roy Parker (chair)

University of Colorado Boulder, Boulder, USA

Prof. Janet Rossant

SickKids Research Institute, Toronto, Canada

Prof. Massimo Scanziani

UCSF Center for Integrative Neuroscience, San Francisco, USA

Prof. Alexander Schier

Biozentrum, University of Basel, Switzerland

Period	Member	Institution
2019	Andrea Musacchio	Max Planck Institute of Molecular Physiology, Dortmund, Germany (ad hoc)
2014-2019	Adriano Aguzzi	Institute of Neuropathology, University Hospital Zurich, Switzerland
2014-2019	Adrian Bird	University of Edinburgh, UK
2018	Tobias Bonhoeffer	Max Planck Institute of Neurobiology, Martinsried, Germany (ad hoc)
2014-2017	Lewis Cantley	Harvard Medical School
2013-2017	Anne Ephrussi	EMBL, Heidelberg, Germany
2010-2017	Jeff Porter	Novartis Institutes for BioMedical Research, Cambridge, USA
2008-2014	Martin Schwab	University and ETH Zurich, Zurich, Switzerland
2007-2014	David Allis	The Rockefeller University, New York, USA
2005-2012	Gideon Dreyfuss	Howard Hughes Medical Institute, University of Pennsylvania, Philadelphia, USA
2005-2012	Catherine Dulac	Howard Hughes Medical Institute, Harvard University, Cambridge, USA
2010	Adam Antebi	Max Planck Institute for Biology of Ageing, Cologne, Germany (ad hoc)
2010	Adrian Bird	University of Edinburgh, Edinburgh, UK (ad hoc)
2010	Sarah Elgin	Washington University, St. Louis, USA (ad hoc)
2007-2010	Mu-Ming Poo	University of California, Berkeley, USA
2009	Tobias Bonhoeffer	Max Planck Institute of Neurobiology, Martinsried, Germany (ad hoc)
2009	Thomas Jenuwein	Max Planck Institute of Immunobiology, Freiburg, Germany (ad hoc)
2008-2009	Jan de Vries	Novartis Institutes for Biomedical Research, Basel, Switzerland
2003-2008	Tony Hunter	Salk Institute for Biological Studies, San Diego, USA
2001-2008	Martin Raff	University College London, London, UK
2007	Victor Ambros	University of Massachusetts, Amherst, USA (ad hoc)
2007	Sara Courtneidge	Burnham Institute for Medical Research, La Jolla, USA (ad hoc)
2007	Peter Parker	Cancer Research UK London Research Institute, London, UK (ad hoc)
2004-2007	Harald Reuter	University of Bern, Bern, Switzerland
2001-2007	Alex Matter	Experimental Therapeutics Center, Singapore, Singapore
2006	Adrian Bird	University of Edinburgh, Edinburgh, UK (ad hoc)
2006	Sarah Elgin	Washington University, St. Louis, USA (ad hoc)
2006	Moshe Yaniv	SCNRS Institut Pasteur, Paris, France (ad hoc)
2005-2006	Gary Ruvkun	Massachusetts General Hospital, Boston, USA
2005	Mu-ming Poo	University of California, Berkeley, USA (ad hoc)
2005	Peter H. Seeburg	Max Planck Institute of Medical Research, Heidelberg, Germany (ad hoc)
2002-2005	Moshe Yaniv	SCNRS Institut Pasteur, Paris, France
1999-2005	Frank McCormick	University of California, San Francisco, USA
2002-2004	Julio E. Celis	The Danish Cancer Society, Copenhagen, Denmark
2000-2004	Thomas L. Benjamin	Harvard Medical School, Cambridge, MA, USA
1992-2004	Albert Aguayo	McGill University, Montreal, Canada
2001-2002	Paul Herrling	Novartis Corporate Research, Basel, Switzerland
1997-2002	Richard Flavell	John Innes Centre, UK
1998-2001	Michel Caboche	Laboratoire de biologie des semences, INRA, Versailles Cedex, France
1996-2001	Bert Sakmann	Max Planck Institute of Medical Research, Heidelberg, Germany
2000	Ben J. Miflin	Rothamsted Research, Harpenden, UK
1998-2000	Denis Duboule	EPFL, Lausanne, Switzerland
1992-1998	Michael Berridge	The Babraham Institute, Cambridge, UK
1988-1998	Milton Schlesinger	Washington University, St. Louis, USA
1995-1997	Walter Schaffner	University of Zurich, Zurich, Switzerland
1991-1997	Heinz Saedler	Max Planck Institute for Plant Breeding Research, Cologne, Germany
1991-1996	Adrienne Clarke	University of Melbourne, Melbourne, Australia
1989-1995	Ruth Sager	Harvard University, Cambridge, USA
1989-1994	Avram Hershko	Technion, Haifa, Israel
1989-1994	Ueli Schibler	University of Geneva, Geneva, Switzerland
1987-1991	Hans Thönen	Max Planck Institute of Neurobiology, Martinsried, Germany
1985-1991	John Fincham	Cambridge University, Cambridge, UK
1980-1991	Diter von Wettstein	Washington State University, Pullman, USA
1988-1990	Luis Glaser	University of Miami, Miami, USA
1986-1988	Arthur B. Pardee	Dana-Farber Cancer Institute, Boston, USA
1985-1986	Walter Schaffner	University of Zurich, Zurich, Switzerland
1983-1986	Howard Green	Harvard Medical School, Boston, USA
1979-1985	Eric M. Shooter	Stanford University, Stanford, USA
1976-1984	Edmond H. Fischer	University of Washington, Seattle, USA
1979-1983	Walter Gehring	Biozentrum, University of Basel, Basel, Switzerland
1976-1981	Sir Michael G.P. Stocker	Imperial Cancer research Fund Laboratories, London, UK
1976-1980	Efraim Racker	Cornell University, Ithaca, USA
1976-1980	Howard V. Rickenberg	National Jewish Hospital and Research Center, Denver, USA
1977-1978	Charles Weissmann	Institut für Molekularbiologie der Universität Zürich, Zürich, Switzerland